Thiais, France

Pierre Deprez

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 3.6

ph-index = 5

Forward Citations = 43(Granted Patents)


Location History:

  • Thiasis, FR (2009)
  • Thiais, FR (1998 - 2012)

Company Filing History:


Years Active: 1998-2012

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Unveiling the Innovations of Inventor Pierre Deprez from Thiais, FR

Introduction: Meet Pierre Deprez, a visionary inventor hailing from Thiais, FR, with a remarkable portfolio of 9 patents to his name. His groundbreaking work has transcended boundaries and left an indelible mark on the world of inventions.

Latest Patents:

1. "Derivatives of urea and related diamines, methods for their manufacture, and uses therefor": This patent delves into compounds represented in Formula I, offering insights into pharmaceutical compositions, treatment methods for diseases related to the calcium sensing receptor, and innovative manufacturing processes.

2. "Urea derivatives methods for their manufacture and uses thereof": Pierre's invention revolves around compounds of formula (I), their preparation processes, medicinal applications, and pharmaceutical compositions. This patent showcases his prowess in the realm of medicinal chemistry.

Career Highlights: Pierre Deprez has lent his expertise to renowned companies such as Amgen Inc. and Hoechst Marion Roussel. His stint in these esteemed organizations has not only enriched his professional journey but also contributed significantly to the field of pharmaceuticals and healthcare innovations.

Collaborations: Alongside his solo endeavors, Pierre has collaborated with industry stalwarts like Jacques Guillaume and Alain Corbier. Together, they have synergized their talents and knowledge to drive innovation and push the boundaries of scientific discovery.

Conclusion: Inventor Pierre Deprez stands as a beacon of innovation, with a relentless drive to push the boundaries of scientific discovery. His patents and collaborations underscore his commitment to revolutionizing the field of pharmaceuticals and advancing the realm of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…